Human pathogenic microbes : diseases and concerns /

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Mir, Manzoor Ahmad (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: London, United Kingdom : Academic Press, 2022.
Colección:Developments in microbiology.
Temas:
Medical microbiology.
Communicable diseases.
Drug resistance in microorganisms.
Communicable Diseases
Microbiologie m�edicale.
Maladies infectieuses.
Communicable diseases
Drug resistance in microorganisms
Medical microbiology
Electronic books.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • Front Cover
  • HUMAN PATHOGENIC MICROBES
  • HUMAN PATHOGENIC MICROBES: DISEASES AND CONCERNS
  • Copyright
  • Contents
  • List of contributors
  • Preface
  • Acknowledgments
  • Abbreviation list
  • Glossary
  • 1
  • Human pathogenic microbes (bacterial and fungal) and associated diseases
  • 1.1 Introduction
  • 1.1.1 Modes of transmission
  • 1.2 Human-pathogen interaction
  • 1.3 Human pathogenic fungal microorganisms
  • 1.3.1 Candida species
  • 1.3.2 Aspergillus species
  • 1.3.3 Cryptococcus species
  • 1.4 Human pathogenic fungal diseases
  • 1.4.1 Candidiasis
  • 1.4.2 Aspergillosis
  • 1.4.3 Cryptococcosis
  • 1.5 Human pathogenic bacterial microorganisms
  • 1.5.1 Mycobacterium tuberculosis
  • 1.5.2 Vibrio cholera
  • 1.5.3 Staphylococcus aureus
  • 1.6 Human pathogenic bacterial diseases
  • 1.6.1 Tuberculosis (TB)
  • 1.6.2 Cholera
  • 1.6.3 Streptococcus pneumoniae and other associated infections
  • 1.7 Summary and future perspectives
  • References
  • 2
  • Evolution of antimicrobial drug resistance in human pathogenic bacteria
  • 2.1 Introduction
  • 2.2 Current status of resistance to antibacterial drugs
  • 2.3 Surveillance of antibacterial resistance/tolerance
  • 2.4 Molecular mechanisms of antimicrobial drug resistance in human pathogenic bacteria
  • 2.5 Resistance to antibacterial drugs in selected bacteria of international concern
  • 2.5.1 Escherichia coli-resistance to third-generation cephalosporins and fluoroquinolones
  • 2.5.2 Klebsiella pneumoniae-resistance to third-generation cephalosporins and to carbapenems
  • 2.5.3 Staphylococcus aureus-resistance to methicillin
  • 2.5.4 Streptococcus pneumoniae-resistance (nonsusceptibility) to penicillin
  • 2.5.5 Nontyphoidal salmonella-resistance to fluoroquinolones
  • 2.5.6 Shigella species-resistance to fluoroquinolones
  • 2.5.7 Neisseria gonorrhoeae-decreased susceptibility to third-generation cephalosporins
  • 2.6 Economic burden of antibacterial resistance and its impacts on human health
  • 2.6.1 Health burden
  • 2.6.2 Economic burden
  • 2.7 Surveillance of antimicrobial drug resistance in disease-specific programs
  • 2.7.1 Surveillance of drug-resistant tuberculosis
  • 2.7.2 Surveillance of antimalarial therapeutic efficacy and resistance
  • 2.7.3 Surveillance of anti-HIV drug resistance
  • 2.7.4 Surveillance of anti-influenza drug resistance
  • 2.8 Evolution of drug resistance in mycobacterium tuberclosis
  • 2.8.1 Global public health response to drug-resistant tuberclosis
  • 2.9 Future perspectives
  • References
  • 3
  • Evolution of antimicrobial drug resistance in human pathogenic fungi
  • 3.1 Introduction
  • 3.2 Molecular mechanisms governing antimicrobial drug resistance phenomenon in the human pathogenic fungi
  • 3.2.1 Transport alteration: drug efflux via overexpression/activation of membrane transporters
  • 3.2.2 Target alteration: altered ergosterol biosynthesis
  • 3.2.3 Genomic alterations/genomic plasticity

Ejemplares similares